J. Barone

Meningococcal disease in New York City, 1973 to 1978. Recognition of groups y and W-135 as frequent pathogens.

J. Marr, W. Lee, S. Schaefler, 1980, JAMA.

Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.

R. Curtis, N. Giacona, J. Barone, 1984, Archives of internal medicine.

Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients.

W. Risser, D. Simpkins, P. Clark, 1987, The Pediatric infectious disease journal.

Declining Susceptibility to Neomycin and Polymyxin B of Pathogens Recovered in Otitis Externa Clinical Trials

H. Cantrell, F. Duncanson, Ephraim Katz, 2004, Southern medical journal.

Warfarin pharmacogenomics.

B. Malone, Jiayi Li, Shan Wang, 2009, P & T : a peer-reviewed journal for formulary management.

Pharmacokinetic profile of cefixime in man.

R. Faulkner, A. Yacobi, B. Silber, 1987, The Pediatric infectious disease journal.

Bioequivalency of oral suspension formulations of cefixine

R. Faulkner, B. Silber, J. Barone, 1989, Biopharmaceutics & drug disposition.

Bioequivalency of solid oral dosage forms of cefixime

R. Faulkner, B. Silber, L. Sia, 1988 .